UC vs. Harvard: Round 2 in CRISPR fight
The University of California is fighting back in its quest to regain control over the rights to the powerful gene-editing technology known as CRISPR-Cas9. On Monday, UC is arguing its appeal of the U.S. Patent Office’s decision in 2017 that the valuable patents on the revolutionary tool belong to the... Continue reading